<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190126042496N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-02-01</date_registration>
      <primary_sponsor>Neurofunctional Research Center of Shohada Tajrish Hospital</primary_sponsor>
      <public_title>Clinical and biomechanical outcomes following decompression of central canal and lateral recess simultaneous stenosis, with a focus on multilevel stenosis: A randomized comparison of microscopic bilateral laminotomy versus total laminectomy with posterior spinal fusion.</public_title>
      <acronym></acronym>
      <scientific_title>Clinical and biomechanical comparison of microscopic bilateral laminotomy versus total laminectomy with posterior spinal fusion for decompression of central canal and lateral recess simultaneous stenosis, with a focus on multilevel stenosis: A prospective comparative study.</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-01-25</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>76</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68186</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: By using a random number table (simple randomization), all patients who meet all the inclusion and exclusion criteria will be consecutively recruited from outpatient clinics and randomized into one of the study arms by the statistician. (1:1).</study_design>
      <phase>N/A</phase>
      <hc_freetext>Patients with multilevel spinal canal stenosis, simultaneous stenosis of the central canal, and lateral recess..</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1(Group A): A group of patients with multi-level spinal canal stenosis, simultaneously stenosis of the central canal and lateral recess, who will be scheduled to undergo lumbar decompression surgery via microscopic bilateral laminotomy through a unilateral approach. Intervention 2: Intervention group 2 (Group B): A group of patients with multi-level spinal canal stenosis, simultaneously stenosis of the central canal and lateral recess, who will be scheduled to undergo lumbar decompression surgery via total laminectomy and partial medial facetectomy with posterior spinal fusion (bilaterally removal of the bony lamina ≥ 3 lamina, spinous processes, and interspinous intertransverse ligaments and medial facet, as well as posterior spinal fusion with pedicle screw fixation to prevent instability).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is No more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohammadreza Shahmohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Next to Taleghani hospital, Shahid Araabi St., Yaman St.,Shahid Chamran highway, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985717443</zip>
        <telephone>+98 21 23871</telephone>
        <email>mr_shahmohammadi@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammadreza Shahmohammadi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Next to Taleghani hospital, Shahid Araabi St., Yaman St.,Shahid Chamran highway, Tehran, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985717443</zip>
        <telephone>+98 21 23871</telephone>
        <email>mr_shahmohammadi@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Between 30- and 75-year-old age
Multi-level canal stenosis (≥ 3 levels)
Stenosis of both the central canal (mild to moderate) and the lateral recess simultaneously.
Failure of conservative therapy for radicular pain after six months.
Radicular pain predominates over claudication(mild).</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with severe stenosis of the central canal.
Patients with severe neurogenic claudication suffer from leg pain that limits their ability to stand or walk.
Extruded discs or those requiring discectomy
Osteoporotic patients with a T score &lt; -1.5
Previous spinal surgery history (laminotomy , laminectomy, or posterior spinal fusion )
Serious medical conditions such as congestive heart failure, cirrhosis, and other chronic diseases that preclude surgical procedures.
Even though patients develop cardiac, renal, or pulmonary disorders during the study, they will be excluded.
Current metabolic or rheumatologic and inflammatory disorders requiring corticosteroid consumption.
Spinal deformity</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M48.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Spinal stenosis</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1(Group A): A group of patients with multi-level spinal canal stenosis, simultaneously stenosis of the central canal and lateral recess, who will be scheduled to undergo lumbar decompression surgery via microscopic bilateral laminotomy through a unilateral approach.</i_keyword>
      <i_keyword>Intervention group 2 (Group B): A group of patients with multi-level spinal canal stenosis, simultaneously stenosis of the central canal and lateral recess, who will be scheduled to undergo lumbar decompression surgery via total laminectomy and partial medial facetectomy with posterior spinal fusion (bilaterally removal of the bony lamina ≥ 3 lamina, spinous processes, and interspinous intertransverse ligaments and medial facet, as well as posterior spinal fusion with pedicle screw fixation to prevent instability)</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>VAS changes : Post-op versus pre-op VAS changes for leg pain and back pain. Timepoint: VAS scores will be measured before surgery, after 6-9 months, and after 18-24 months to determine the extent of pain relief. Method of measurement: The patient's pain level is assessed on a horizontal line of 100 mm that its left end represents no pain, and the right end corresponds to the most severe pain that can be experienced. The patient is asked to mark the pain intensity they are experiencing currently.</prim_outcome>
      <prim_outcome>Duration of hospitalization. Timepoint: Total number of hospital admission days. Method of measurement: Number of days staying in hospital with reference to medical records.</prim_outcome>
      <prim_outcome>Duration of operation. Timepoint: During surgery. Method of measurement: The number of hours it takes for the operation to be completed.</prim_outcome>
      <prim_outcome>Blood transfusion: The number of patients requiring blood transfusions. Timepoint: During surgery. Method of measurement: Based on doctor's diagnosis.</prim_outcome>
      <prim_outcome>Wound infection and discharge: Incidence of postoperative wound infection and discharge. Timepoint: Immediately after surgery until the end of the hospitalization period for each patient (up to 1 month after surgery ). Method of measurement: Based on doctor's diagnosis.</prim_outcome>
      <prim_outcome>Incidental durotomy: An accidental puncture or laceration of dura during a procedure. Timepoint: During surgery. Method of measurement: Based on doctor's diagnosis.</prim_outcome>
      <prim_outcome>Meningitis: Incidence of meningitis after surgery. Timepoint: Immediately after surgery until the end of the hospitalization period for each patient (up to 1 month after surgery). Method of measurement: Based on doctor's diagnosis.</prim_outcome>
      <prim_outcome>Revision surgery: The number of patients requiring revision surgery either due to technical issues or infections. Timepoint: Immediately after surgery until the end of the follow-up time. Method of measurement: Based on doctor's diagnosis.</prim_outcome>
      <prim_outcome>Root injury: Incidence of root injury during surgery. Timepoint: During surgery. Method of measurement: Based on doctor's diagnosis.</prim_outcome>
      <prim_outcome>Vacuum sign: Incidence of a collection of gas in the intervertebral disc space. Timepoint: Immediately after surgery, after 6-9 months, and after 18-24 months follow-up. Method of measurement: Based on doctor's diagnosis via lateral plain radiographs.</prim_outcome>
      <prim_outcome>Adjacent segment disease (ASD): Degeneration of the mobile spinal segments between upper instrumented vertebra (UIV) and UIV+2 leading to spinal canal stenosis or discopathy . Timepoint: After 18-24 months follow-up. Method of measurement: Anteroposterior and lateral plain radiographs, and computed tomography (CT).</prim_outcome>
      <prim_outcome>Hypermobility: Increased range of motion between UIV and UIV+2. Timepoint: Immediately after surgery, after 6-9 months, and after 18-24 months follow-up. Method of measurement: Flexion-extension radiographs.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Proximal junctional kyphosis (PJK): A rise of over 20° in the Cobbs' angle between the lower endplate of the upper instrumented vertebra (UIV) and the upper endplates of two super-adjacent vertebrae between the immediate postoperative and after follow-up time. Timepoint: Immediately after surgery, after 6-9 months, and after 18-24 months follow-up. Method of measurement: The standing lateral radiograph.</sec_outcome>
      <sec_outcome>Sagittal vertical axis (SVA): The length of a horizontal line connecting the superior-posterior endplate of S1 to a vertical plumb line that drawn from the mid-point of the C7 vertebral body. This horizontal distance should be located within ± 5mm of the superior-posterior endplate of S1. Timepoint: Immediately after surgery, after 6-9 months, and after 18-24 months follow-up. Method of measurement: The standing lateral spine radiographs.</sec_outcome>
      <sec_outcome>Pelvic incidence (PI): The angle is formed by the perpendicular line running from the midpoint of the sacral plate and a line connecting that point to the center of the bicoxofemoral axis that serves as the foundation for all other spinal curves. Timepoint: Immediately after surgery, after 6-9 months, and after 18-24 months follow-up. Method of measurement: The standing lateral radiograph.</sec_outcome>
      <sec_outcome>Pelvic tilt (PT): The angle between the vertical axis and the line connecting the center of the coxofemoral axis to the midpoint of the S1 endplate. Timepoint: Immediately after surgery, after 6-9 months, and after 18-24 months follow-up. Method of measurement: The standing lateral radiograph.</sec_outcome>
      <sec_outcome>Sacral slope (SS): The angle between the horizontal reference line and the line parallel to the superior plate of S1. Timepoint: Immediately after surgery, after 6-9 months, and after 18-24 months follow-up. Method of measurement: The standing lateral radiograph.</sec_outcome>
      <sec_outcome>Lumbar lordosis (LL): The angle between the caudal endplate of L5 and the upper plane of the L1 lumbar vertebra. Timepoint: Immediately after surgery, after 6-9 months, and after 18-24 months follow-up. Method of measurement: The standing lateral radiograph.</sec_outcome>
      <sec_outcome>Pelvic incidence-lumbar lordosis mismatch (DPILL = PI-LL): A mismatch between pelvic incidence and lumbar lordosis strongly correlates with the sagittal balance and has become a key element in treating adult deformities. Timepoint: Immediately after surgery, after 6-9 months, and after 18-24 months follow-up. Method of measurement: The difference between pelvic incidence and lumbar lordosis.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Neurofunctional Research Center of Shohada Tajrish Hospital</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-01-26</approval_date>
        <contact_name>Institutional Research Ethics Committee - Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>3rth floor, Faculty of Medicine, next to Taleghani Hospital, Evin, Shahid Chamran Highway Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
